Data from the World Health Organization's Global Influenza Surveillance
Network indicate that the H5N1 strains that have been circulating are susceptible
to 2 neuraminidase inhibitor antiviral drugs approved to treat human influenza
infections in some countries: oseltamivir (sold as Tamiflu, available as
capsules or an oral suspension) and zanamivir (sold as Relenza, only available
in an inhaled form).
In order to establish that Relenza™ is effective in humans infected with bird flu, clinical data from humans will be needed.
|
relenza - Google News
|
GSK pushes Relenza for flu prep - FiercePharma
Thu, 04 Sep 2008 14:39:14 GMT
GSK pushes Relenza for flu prepFiercePharma, DC - Sep 4, 2008One option for employers: Buy Relenza at a 31 percent discount off the wholesale price. Option Two: Reserve Relenza at a locked-in price. ... |
|
|
GlaxoSmithKline Offers New Purchasing Options to Help Employers ... - CNNMoney.com (press release)
Wed, 03 Sep 2008 12:14:05 GMT
|
|
Glaxo offers corporate plan for its flu drug - Reuters
Wed, 03 Sep 2008 19:26:40 GMT
|
Biota records small year-end loss - Australian Life Scientist
Fri, 05 Sep 2008 03:09:08 GMT
Biota records small year-end lossAustralian Life Scientist, Australia - 20 hours agoBiota had taken GSK to court claiming it had failed to promote Biota's flu treatment Relenza properly. The case was recently settled, with Biota accepting ... |
|
|
Bird Flu Suits To Be Worn By Hospital Staff - UKMedix Health News
Thu, 04 Sep 2008 18:20:22 GMT
|
|
Biota records loss due to Relenza battle - LIVENEWS.com.au
Mon, 25 Aug 2008 06:57:56 GMT
|
|
Glaxo offers program to boost employer antiviral stockpiling - CIDRAP
Wed, 03 Sep 2008 22:14:19 GMT
|
Preliminary Final Report and Annual Report - Sydney Morning Herald
Mon, 25 Aug 2008 00:23:20 GMT
Preliminary Final Report and Annual ReportSydney Morning Herald, Australia - Aug 24, 2008Relenza royalties were $20.5 million (2007: $39.8m) reflecting the volatility of government orders for influenza pandemic stockpiles on GlaxoSmithKline ... |
|
Biota clears the board in wake of settlement - The Age
Mon, 25 Aug 2008 13:59:15 GMT
Biota clears the board in wake of settlementThe Age, Australia - Aug 25, 2008The legal dispute between the two parties, which arose over GSK's efforts to promote the Biota-developed Relenza antiviral, was settled out of court last ... |
|
|
Fairfax Media axes 5% of staff, union to meet management - Business Spectator
Tue, 26 Aug 2008 07:22:50 GMT
|